Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ESRRG | P62508 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13267172 | 0.89 | NPC1 (0.41) | NPC1RAB9ACA2ESRRG | |
| SCHEMBL10287224 | 0.87 | HPGDS (0.51) | NPC1RAB9A | |
| SCHEMBL254900 | 0.87 | ANPEP (0.39) | NPC1RAB9A | |
| SCHEMBL13266885 | 0.86 | ANPEP (0.52) | NPC1 | |
| SCHEMBL13245022 | 0.86 | — | — | |
| SCHEMBL254610 | 0.86 | ANPEP (0.41) | NPC1RAB9AESRRG | |
| SCHEMBL405554 | 0.85 | TAS1R3 (0.50) | NPC1RAB9A | |
| SCHEMBL255108 | 0.85 | ANPEP (0.43) | NPC1RAB9AESRRG | |
| SCHEMBL13459333 | 0.84 | NPC1 (0.43) | NPC1RAB9ACA2ESRRG | |
| SCHEMBL13266884 | 0.84 | EPHX2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012031298-A2 | ETHYNYLBENZENE DERIVATIVES | DUKE UNIVERSITY (US) | 2012-03-08 | — | — | WO | disclosed |
| US-20100190766-A1 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. (US) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190766-A1 | ANTIBACTERIAL AGENTS | MRPL21, SI, ABCB11 | NPC1 299/4885RAB9A 509/4885CA2 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.